Differentiation HCMP / Amyloidosis / athletes heart / hypertension is possible — pattern recognition 

Rules to remember for normal vs pathological

  • A certain basal to apical gradient is visible in all forms of myocardial wall thickening & even in healthy individuals

  • Basal/apical gradient — Laplace-Law— basal more wall stress (larger radius) + apical more matrix formation of the myocytes ➜ less wall stress

  • LA Strain as a differentiation for myocardial wall thickening ➜ storage disease/restrictive CMP with the lowest values ➜ hypertensive heart disease with an LASr >20%, amyloidosis <20% ➜ in HCMP, a reduction of all 3 LA Strain phases is possible

  • PSI mean values ➜ HCMP (6%), Amyloidosis (7%), around 2% in healthy individuals

H(O)CMP

  • HCM GLS mean value of -11,7% vs. Hypertensive heart disease "low-normal" -17,8%

  • Hypertrophied segments in HCM around -12%, also non-hypertrophied show reduction

  • Mortality increases in Strain >-16%; with a GLS >-10% 10-year-mortality >75% (H(O)CMP)

  • GLS more positive than -10% ➜ increased probability for ventricular arrhythmias in H(O)CMP

  • H(O)CMP — all morphological LV forms are possible

  • Strain reduction in HCMP, like LGE in MRI (detection of end-stage fibrosis)

  • Subclinical & early fibrosis detection (no LGE in MRI)

  • LA Strain values improve with Mavacamten (LASr (baseline 20,5%) 2,8% in 56 weeks, LASct (baseline -8,7%) -1,2%) ➜ reverse remodelling of the LA

  • Significant improvement of the GLS in HOCMP in reversible myosin inhibitors (especially in the areas with the most significant reduction)

  • LASr as a predictor in HCM for ≤6METS (cut-off ≤8% — Limitation 3D LA Strain)

  • Apical HCMP with a reduction in the hypertrophied segments & potentially "Blueberry on top" ➜ "early" time to peak Strain sometimes visible in the apical hypertrophied segments

Sun 2019; Alfonso 2012; Liu 2017; Saio et al., PLOS ONE 2022; Altersberger, Genger 2023


Cut-offs to remember

Amyloid heart disease

  • Gradient & apical sparing in Amyloid heart disease in all forms visible (AL, ATTR); Amyloid heart disease ➜ Cherry on Top = apical sparing

  • All strain parameters have prognostic information for amyloid heart disease (LV, RV, LA, RA Strain). LASr is the strongest parameter. Thicker walls ➜ worse Strain (GLS -14,8% with IVS 16mm vs. GLS  -8% with IVS 18mm ➜ FWS -20,7% vs. -13,4% ➜ LASr 23,4% vs. 9,1%; RASr 22,9% vs. 8,1%)

  • In LASr 13,4% survival of 25% in 4a ➜ the worse the strain, the more survival is reduced

  • Relative apical sparing (RAS) can be calculated in the 17-segment model; RAS ≥1 = (Mean value 5 apical segments / (Mean value 6 basal + 6 midventricular segments)

  • Early forms ➜ often basal to apical gradient with GLS >-15% ➜ use LA Strain as well (LASr <20% in restrictive CMP before restrictive filling)

  • Stabilisation in TTR stabilizers therapy of GLS -10,6% vs -11,3% in 1 year follow-up in SR ➜ LASr improvement was significant 10,5% vs 11,9% in 1 year follow-up; reduction over time in all parameters in AFIB; untreated GLS reduction is -1% per year; -10,4% associated as cut-off for poor outcomes

  • RV GLS >-17% as risk marker (2,8 fold risk of CD death)

Morbus Anderson-Fabry

  • Strain reduction in ≥1 Segment also without myocardial wall thickening; inferolateral (basal, medial) and lateral strain reduction

  • GLS reduction ➜ progress

  • Improvement of LASr ➜ successful therapy (GLS does not change)

  • Hypertension (CATEGORY like Fabry, Amyoid heart disease)

  • Borderline normal Strain with -17,8% ➜ Tip: GLS -16%, think about HFpEF, in a relevant basal/apical gradient, think about amyloid heart disease

Others

  • Diffusely reduced strain in mitochondrial disease

Endurance athletes

  • IVS >11mm & GLS ≥-18% 79% specificity for pathological LVH in normal EF ➜ Tip: in athletes perform handgrip or similar (easy) stresstest in unclear and borderline GLS (quick improvement during exercise); be aware of structural heart disease in low or low-normal GLS

HCM

  • Mean GLS -11,7%, prognosis (and arrhythmias) worse ➜ >-16%; severely reduced prognosis in GLS >-10% = Tip: also segments without LVH can be diseased (subclinically) and show a reduced Strain ➜ no LGE in MRI (beginning fibrosis), strain otherwise marker for LGE in MRI

Amyloid heart disease

  • LASr <20%, HTN >20%, lowest values in restrictive CMPs; relative apical sparing ≥1 or GLS / EF >4,1 amyloid heart disease possible ➜ Tip: in early stages and in unclear strain reduction (with clear basal to apical gradient) think about it (GLS >-16%, IVS 11-12mm, LASr reduction with relatively preserved GLS)

Int J Cardiovasc Sci. 2024; 37:e20240082; Eur Heart J Cardiovasc Imaging
2024 Apr 30;25(5):678-686. doi: 10.1093/ehjci/jead344.

Pattern recognition

H(O)CMP

H(O)CMP

aHCM

H(O)CMP

H(O)CMP

aHCM

Amyloidosis

Amyloidosis

Athlete

Amyloidosis

Amyloidosis

Athlete

The contents of the website, including the videos, were created without influence from third parties.

The contents of the website, including the videos, were created without influence from third parties.

The Strain Book

Represented by Dr. Martin Altersberger

Contact: heart.lungs.ultrasound@gmail.com

The Strain Book

Represented by Dr. Martin Altersberger

Contact: heart.lungs.ultrasound@gmail.com

© 2026 The Strain Book by Dr. Martin Altersberger. All rights reserved.

© 2026 The Strain Book by Dr. Martin Altersberger. All rights reserved.

© 2026 The Strain Book by Dr. Martin Altersberger. All rights reserved.